18 Sertoli-leydig cell tumors of the ovary: analysis of a single institution database

Background: An improved understanding of the clinical presentations, histological character, and therapeutic approaches relevant to ovarian Sertoli-Leydig cell tumors (SLCTs), is of value to better treat this disease. Methods: We reviewed the medical records of 18 ovarian SLCT patients seen in our center over the last 10 years. Combined with available literature, we conducted a retrospective study and analysis of this patient group. Results: We observed that the patients initially presented at ages ranging from 23 to 72 years, displayed various clinical disease manifestations, and all patients were diagnosed with stage I tumors. Most tumors were solid masses, unilateral lesions, and carried a favorable prognosis. Conclusions: Data gathered favor both improved clinical management and better prognostic for patients with SLCT.